Budesonide and fluticasone propionate exertdifferential effects on human bronchial epithelial cells exposed to streptococcus pneumoniae and viral mimetic Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016
Anti-inflammatory effect of the combination of a long acting β2-agonist (salmeterol) and a corticosteroid (fluticasone propionate) on human airway epithelial cells following staphylococcus aureus virulence factors challenge Source: Eur Respir J 2006; 28: Suppl. 50, 104s Year: 2006
Chlamydia pneumoniae infection in asthmatic patients Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009
Treatment of patients with bronchial asthma and latent chlamydophila pneumoniae and mycoplasma pneumoniae infections by a doxycycline Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002
Co-treatment with clarithromycin and dexamethasone on murine mycoplasma pneumoniae pneumonia model Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009
Anti-inflammatory effect of the combination of a long acting beta2-agonist (salmeterol) and a corticosteroid (fluticasone propionate) on human airway epithelial cells following Staphylococcus aureus infection Source: Eur Respir J 2005; 26: Suppl. 49, 98s Year: 2005
Chlamydia pneumoniae infection in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 52s Year: 2004
Comparison of immunomodulating effects among clarithromycin, dexamethasone and levofloxacin on the murine model of mycoplasma pneumoniae pneumonia Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases Year: 2008
The role of Chlamydia pneumoniae infection in bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 681s Year: 2005
Chlamydia pneumoniae and mycoplasma pneumoniae seropositivities in children with bronchial asthmaSource: Eur Respir J 2006; 28: Suppl. 50, 849s Year: 2006
Chlamydia pneumoniae infection in patients with mild asthma Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011
Comparison of fluticasone propionate and budesonide on phagocytosis of common respiratory pathogens in COPD patients Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011
Differential effects of budesonide and fluticasone propionate on bacterial recognition receptors in COPD macrophages Source: International Congress 2016 – Airway response to infection Year: 2016
Chlamydia pneumoniae infection and severe asthma exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 221s Year: 2002
Immunomodulating effect of clarithromycin in a murine model of mycoplasma pneumoniae pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 737s Year: 2007
Treatment of chlamydia pneumoniae infection in asthmatic patients Source: Eur Respir J 2004; 24: Suppl. 48, 410s Year: 2004
Infection with mycoplasma pneumoniae and chlamydia pneumoniae in non-allergic late-onset asthma Source: Eur Respir J 2006; 28: Suppl. 50, 376s Year: 2006
Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Source: Eur Respir J 2001; 17: 241-245 Year: 2001
Chlamydia pneumoniae and their potential role in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 421s Year: 2003
Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways and exacerbations of bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008